Title Category Credit Event datesort ascending Cost
Adaptive Protocols and Practical Strategies for the Use of Novel Anticoagulation Reversal Agents
  • Cardiology
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
11/10/2020 $0.00 This interprofessional, community Grand Rounds initiative is targeted to addressing the professional practice of physicians, pharmacists, nurse practitioners, physician assistants, nurses, and other healthcare professionals, who manage patients who are taking anticoagulation therapy, and who may require reversal agents for direct oral anticoagulants to address acute bleeding complications.
Revolutionizing Outcomes in Gynecologic Surgery: The Pivotal Role of Iron Deficiency Anemia
  • AAPA Category I CME
  • AMA PRA Category 1 Credit™
  • ANCC
11/09/2020 $0.00 Iron deficiency anemia is a far-reaching condition of immense clinical impact in women’s health, with implications ranging from the global, epidemiological scale, to treatment by individual OB/GYNs and gynecologic surgeons, and most importantly, to individual patient outcomes. As such, this educational initiative is designed to address the myriad challenges of iron deficiency anemia (IDA) in women’s health using a dynamic, multifaceted approach targeted to OB/GYNs and gynecologic laparoscopists.
Navigating a Changing Landscape in TNBC: Pharmacist-Focused Strategies in the Era of Immunotherapy
  • Oncology
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • Participation
10/20/2020 $0.00 Symposium attendees will gain insights into the molecular heterogeneity and diverse clinical features of TNBC, a condition which comprises 15-20% of all breast cancer cases, and has historically had limited treatment options, been associated with earlier age of onset, more aggressive disease course, and poorer prognosis.
Optimizing Outcomes in Iron Deficiency Anemia: Adaptive Approaches for the OB/GYN
  • AMA PRA Category 1 Credit™
  • Participation
10/17/2020 $0.00 Iron deficiency anemia is a far-reaching condition of immense clinical impact in women’s health, with implications ranging from the global, epidemiological scale, to individual OB/GYN practices, and most importantly, to individual patients. As such, this educational initiative is designed to address the myriad challenges of iron deficiency anemia (IDA) in women’s health using a dynamic, multifaceted approach targeted to OB/GYNs.
Adaptive Protocols and Practical Strategies for the Use of Novel Anticoagulation Reversal Agents
  • Cardiology
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
10/14/2020 $0.00 This interprofessional, community Grand Rounds initiative is targeted to addressing the professional practice of physicians, pharmacists, nurse practitioners, physician assistants, nurses, and other healthcare professionals, who manage patients who are taking anticoagulation therapy, and who may require reversal agents for direct oral anticoagulants to address acute bleeding complications.
Stepping Beyond the Status Quo in Heart Failure: The Revolutionary Role of SGLT2 Inhibition
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
  • Participation
10/13/2020 $0.00 This Grand Rounds initiative is targeted to cardiologists, endocrinologists, primary care physicians, pharmacists, nurses, nurse practitioners, and physician assistants. Designed to foster meaningful interprofessional and interdisciplinary collaboration, this accredited activity will explore the evolution of SGLT2 inhibition in the era of cardiovascular outcomes trials (CVOTs), as well as evaluate foundational mechanisms linking type 2 diabetes (T2D) to heart failure (HF).
Optimizing Outcomes in Iron Deficiency Anemia: Adaptive Approaches for the OB/GYN
  • AMA PRA Category 1 Credit™
  • Participation
10/08/2020 $0.00 ACOG Virtual CME Forum
Stepping Beyond the Status Quo in Heart Failure: The Revolutionary Role of SGLT2 Inhibition
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
  • Participation
10/03/2020 $0.00 This Grand Rounds initiative is targeted to cardiologists, endocrinologists, primary care physicians, pharmacists, nurses, nurse practitioners, and physician assistants. Designed to foster meaningful interprofessional and interdisciplinary collaboration, this accredited activity will explore the evolution of SGLT2 inhibition in the era of cardiovascular outcomes trials (CVOTs), as well as evaluate foundational mechanisms linking type 2 diabetes (T2D) to heart failure (HF).
Managing Cardiovascular Disease in the Time of COVID-19
  • AMA PRA Category 1 Credit™
  • Participation
$0.00 As the novel coronavirus, SARS-CoV-2, spreads across the globe, and as confirmed cases of COVID-19 infection continue to climb, we are being ushered into circumstances which are unprecedented in modern times. It is thus absolutely vital that cardiologists, who are tasked with managing a patient population with chronic cardiovascular disease (CVD) that is, resultantly, at high risk for severe manifestations of COVID-19, be informed regarding adaptive ways to maintain effective CVD disease management while also keeping their patients safe.
Oncology Clinical Briefing: Expert Insights for Managing Bladder Cancer in the Time of COVID-19
  • Oncology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00 As the novel coronavirus, SARS-CoV-2, spreads across the globe, and as confirmed cases of COVID-19 infection continue to climb, we are being ushered into circumstances which are unprecedented in modern times. It is thus absolutely vital that oncology clinicians, who manage a patient population at very high risk for severe manifestations of COVID-19, be informed regarding adaptive ways to keep their patients safe. To help meet that need, this online educational activity will review the ever-changing epidemiology of COVID-19 and identify primary infection risk concerns for cancer patients.

Pages